General Information of Drug Off-Target (DOT) (ID: OTNE7W96)

DOT Name tRNA (FTSJ1)
Synonyms cytidine(32)/guanosine(34)-2'-O)-methyltransferase (EC 2.1.1.205; 2'-O-ribose RNA methyltransferase TRM7 homolog; Protein ftsJ homolog 1
Gene Name FTSJ1
Related Disease
Hepatocellular carcinoma ( )
Intellectual disability, X-linked 9 ( )
X-linked complex neurodevelopmental disorder ( )
Epilepsy ( )
Intellectual disability, X-linked 1 ( )
Obesity ( )
Trichohepatoenteric syndrome ( )
X-linked intellectual disability ( )
Non-syndromic X-linked intellectual disability ( )
Hyperglycemia ( )
Streptococcal B infection ( )
UniProt ID
TRM7_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
2.1.1.205
Pfam ID
PF01728
Sequence
MGRTSKDKRDVYYRLAKENGWRARSAFKLLQLDKEFQLFQGVTRAVDLCAAPGSWSQVLS
QKIGGQGSGHVVAVDLQAMAPLPGVVQIQGDITQLSTAKEIIQHFKGCPADLVVCDGAPD
VTGLHDVDEYMQAQLLLAALNIATHVLKPGGCFVAKIFRGRDVTLLYSQLQVFFSSVLCA
KPRSSRNSSIEAFAVCQGYDPPEGFIPDLSKPLLDHSYDPDFNQLDGPTRIIVPFVTCGD
LSSYDSDRSYPLDLEGGSEYKYTPPTQPPISPPYQEACTLKRKGQLAKEIRPQDCPISRV
DTFPQPLAAPQCHTLLAPEMEDNEMSCSP
Function
Methylates the 2'-O-ribose of nucleotides at positions 32 and 34 of the tRNA anticodon loop of substrate tRNAs. Requisite for faithful cytoplasmic translation. Requires THADA for methylation of the nucleotide at position 32 of the anticodon loop of substrate tRNAs. Requires WDR6 for methylation of the nucleotide at position 34 of the anticodon loop of substrate tRNAs. Promotes translation efficiency of the UUU codon. Plays a role in neurogenesis. Required for expression of genes involved in neurogenesis, mitochondrial translation and energy generation, and lipid biosynthesis. Requisite for RNA-mediated gene silencing. May modify position 32 in tRNA(Arg(ACG)), tRNA(Arg(CCG)), tRNA(Arg(UCG)), tRNA(Cys(GCA)), tRNA(Cys(ACA)), tRNA(Gln(CUG)), tRNA(Gln(UUG)), tRNA(Gly(CCC)), tRNA(Leu(CAG))/tRNA(Leu(CAA)), tRNA(Leu(A/IAG)), tRNA(Leu(UAG)), tRNA(Phe(GAA)), tRNA(Pro(AGG))/tRNA(Pro(CGG))/tRNA(Pro(UGG)) and tRNA(Trp(CCA)), and position 34 in tRNA(Phe(GAA)), tRNA(Leu(CAA)), tRNA(Sec(UCA)), and tRNA(Trp(CCA)).
Tissue Specificity
Found in fetal brain, lung, liver and kidney . Widely expressed in adult tissue; with high expression in heart and liver, lower expression in skeletal muscle, kidney, and pancreas and also lowly expressed in brain and lung . In the adult brain, expressed in amygdala, caudate nucleus, corpus callosum, hippocampus and thalamus .
Reactome Pathway
tRNA modification in the nucleus and cytosol (R-HSA-6782315 )

Molecular Interaction Atlas (MIA) of This DOT

11 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Hepatocellular carcinoma DIS0J828 Definitive Altered Expression [1]
Intellectual disability, X-linked 9 DISWT4BP Definitive X-linked [2]
X-linked complex neurodevelopmental disorder DISI3QE9 Definitive X-linked [3]
Epilepsy DISBB28L Strong Biomarker [4]
Intellectual disability, X-linked 1 DISET38E Strong GermlineCausalMutation [5]
Obesity DIS47Y1K Strong Biomarker [6]
Trichohepatoenteric syndrome DISL3ODF Strong Biomarker [4]
X-linked intellectual disability DISYJBY3 Strong Genetic Variation [7]
Non-syndromic X-linked intellectual disability DIS71AI3 Supportive X-linked [5]
Hyperglycemia DIS0BZB5 Limited Biomarker [6]
Streptococcal B infection DISN80QT Limited Biomarker [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of tRNA (FTSJ1). [9]
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of tRNA (FTSJ1). [10]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of tRNA (FTSJ1). [11]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of tRNA (FTSJ1). [12]
Doxorubicin DMVP5YE Approved Doxorubicin increases the expression of tRNA (FTSJ1). [13]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of tRNA (FTSJ1). [16]
Tocopherol DMBIJZ6 Phase 2 Tocopherol decreases the expression of tRNA (FTSJ1). [17]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of tRNA (FTSJ1). [20]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of tRNA (FTSJ1). [21]
Coumestrol DM40TBU Investigative Coumestrol increases the expression of tRNA (FTSJ1). [22]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)
4 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of tRNA (FTSJ1). [14]
Fulvestrant DM0YZC6 Approved Fulvestrant increases the methylation of tRNA (FTSJ1). [15]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of tRNA (FTSJ1). [18]
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 decreases the phosphorylation of tRNA (FTSJ1). [19]
------------------------------------------------------------------------------------

References

1 Nucleoporin Nup155 is part of the p53 network in liver cancer.Nat Commun. 2019 May 14;10(1):2147. doi: 10.1038/s41467-019-10133-z.
2 Four families (MRX43, MRX44, MRX45, MRX52) with nonspecific X-linked mental retardation: clinical and psychometric data and results of linkage analysis. Am J Med Genet. 1999 Jul 30;85(3):290-304.
3 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
4 Phenotype-genotype correlations in 17 new patients with an Xp11.23p11.22 microduplication and review of the literature.Am J Med Genet A. 2015 Jan;167A(1):111-22. doi: 10.1002/ajmg.a.36807. Epub 2014 Nov 25.
5 A loss-of-function mutation in the FTSJ1 gene causes nonsyndromic X-linked mental retardation in a Japanese family. Am J Med Genet B Neuropsychiatr Genet. 2008 Jun 5;147B(4):479-84. doi: 10.1002/ajmg.b.30638.
6 Evaluation of Bacillus subtilis SPB1 biosurfactant effects on hyperglycemia, angiotensin I-converting enzyme (ACE) activity and kidney function in rats fed on high-fat-high-fructose diet.Arch Physiol Biochem. 2017 May;123(2):112-120. doi: 10.1080/13813455.2016.1261902. Epub 2016 Dec 25.
7 Positive association of the FTSJ1 gene polymorphisms with nonsyndromic X-linked mental retardation in young Chinese male subjects.J Hum Genet. 2008;53(7):592-597. doi: 10.1007/s10038-008-0287-x. Epub 2008 Apr 10.
8 Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae.Infect Immun. 2003 Dec;71(12):6857-63. doi: 10.1128/IAI.71.12.6857-6863.2003.
9 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
10 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
11 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
12 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
13 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
14 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
15 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
16 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
17 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
18 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
19 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
20 Genome-wide gene expression profiling of low-dose, long-term exposure of human osteosarcoma cells to bisphenol A and its analogs bisphenols AF and S. Toxicol In Vitro. 2015 Aug;29(5):1060-9.
21 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
22 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.